-
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2024 Earnings Call Transcript
25 Apr 2024 07:28 GMT
… . The RNA inhibitor of treatment drug, siRNA moves to the … from other companies’ clinical trials. And as you know … biosimilar? Iwaaki Taniguchi No, Actemra and Hemlibra. Hidemaru Yamaguchi … unmet medical needs. We would like to offer innovative pharmaceuticals, …
-
Chugai Pharmaceutical : Q1 Results (Jan-Mar 2024)
24 Apr 2024 08:09 GMT
… in the export of Actemra to Roche. Other revenue … Phesgo, a subcutaneous combination drug containing Perjeta.
Specialty … China by the National Medical Products Administration (NMPA) … the treatment of endometriosis in January 2024.
Chugai Pharmaceutical Co., …
-
FDA Updates for Week of March 4, 2024: Wegovy Gets New Indication
09 Mar 2024 14:44 GMT
… pen.
FDA Approves Second Biosimilar of Actemra
The FDA has approved … dosing regimen as the reference medicines. Sandoz, however, would … System Drugs Advisory Committee to discuss the phase 3 trial … allowed patients to complete treatment based on an assessment …
-
Fresenius Kabi’s Biosimilar for Actemra Gets FDA Approval
08 Mar 2024 19:24 GMT
Pictured: Fresenius Kabi's office in Toronto iStock/JHVEPhoto
Another biosimilar approval from the FDA was handed down Thursday, as the regulator approved Fresenius Kabi’s Tyenne biosimilar for Genentech’s Acterma (tocilizumab).
According to …
-
FDA approves second tocilizumab biosimilar; first available in IV, subcutaneous forms
07 Mar 2024 22:26 GMT
… Kabi) was approved for treatment of rheumatoid arthritis, giant … affordable and accessible autoimmune treatment options to patients and … tocilizumab (Actemra, Genentech) to be approved by the FDA.
Tyenne … the-art and affordable medicines around the globe, with …
-
FDA Approves Tocilizumab-aazg as Biosimilar to Actemra for Multiple Indications
07 Mar 2024 15:58 GMT
… 3
For the subcutaneous treatment with rheumatoid arthritis, tocilizumab … was a non-inferiority trial to compare the … information about the clinical trials can be found on … fda.gov/drugs/;news-events-human-drugs/fda-approves-first-biosimilar-actemra …
-
The biotech $100-billion Club: Meet the 14 most valuable drug makers
05 Mar 2024 23:47 GMT
… Food and Drug Administration (FDA) for the treatment of one- … drug conjugates for cancer, among others.
Vertex Pharmaceuticals – $112 billion
The American biotech … 1 trials; VX-548, a non-opioid medicine for acute … as well as vaccines such as Gardasil and …
-
Celltrion applies for Actemra biosimilar CT-P47’s sales license in Korea
29 Feb 2024 02:14 GMT
… the Ministry of Food and Drug Safety (MFDS).
Celltrion has … a global phase 3 clinical trial in 471 RA patients, … the originator drug.
Based on these phase 3 clinical trial results, … S. FDA and the European Medicines Agency (EMA).
Roche's Actemra is …
-
US FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
19 Feb 2024 06:44 GMT
… US Food and Drug Administration (FDA) has approved Xolair … for the emergency treatment of any allergic reactions … Group, and Novartis Pharmaceuticals Corporation work together to … Roche Group’s immunology medicines include: Actemra/RoActemra?(tocilizumab) …
-
‘Astounding amount’ of vasculitis trials opens mixed bag of ‘exciting,’ ‘frustrating’ data
18 Feb 2024 21:39 GMT
… really an astounding amount of trials going on in a … disease.” Image: Healio
These trials are focused primarily on giant … )-6 receptor could impact tocilizumab (Actemra, Genentech) response in GCA. “ … vasculitis led to the ADVOCATE trial, which, in turn, led …